3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
3
Phase 3
2
Phase 2
2
Phase 2/3
1
Phase 1
1
Status
Unknown
3
Completed
3
Terminated
1
Sponsor Class
OTHER
2
INDUSTRY
1
Study Type
Interventional
3
Sponsor
Conditions
Breast Neoplasms
1905
Neoplasms
1528
Prostatic Neoplasms
751
Colorectal Neoplasms
714
Lung Neoplasms
582
Motor Activity
391
Head and Neck Neoplasms
328
Colonic Neoplasms
311
Uterine Cervical Neoplasms
297
Pain
247
Pancreatic Neoplasms
246
Anxiety Disorders
220
Rectal Neoplasms
213
Carcinoma, Hepatocellular
209
Carcinoma, Non-Small-Cell Lung
206
Fatigue
193
Stomach Neoplasms
191
Polycystic Ovary Syndrome
188
Ovarian Neoplasms
185
Precursor Cell Lymphoblastic Leukemia-Lymphoma
177
Brain Neoplasms
168
Urinary Bladder Neoplasms
165
Depression
164
Melanoma
163
Neoplasm Metastasis
162
Esophageal Neoplasms
140
Multiple Myeloma
137
Lymphoma
135
Lymphoma, Follicular
128
Obesity
127
Interventions
Infusion Pumps, Implantable
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase NA
×
Completed
×
Pain, Intractable
×
Clear all
NCT01567345
2024-08-02
PITAC
Institut Cancerologie de l'Ouest
Phase NA
Completed
54 enrolled
NCT01854229
2023-10-18
Prometra Post-Approval Study
Flowonix Medical
Phase NA
Completed
400 enrolled
NCT04096391
2022-05-18
Prosper-001
Evolve Restorative Center
Phase NA
Completed
73 enrolled